These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

282 related items for PubMed ID: 15751768

  • 1. Response to HAART and GB virus type C coinfection in a cohort of antiretroviral-naive HIV-infected individuals.
    Antonucci G, Girardi E, Cozzi-Lepri A, Capobianchi MR, Morsica G, Pizzaferri P, Ladisa N, Sighinolfi L, Chiodera A, Solmone M, Lalle E, Ippolito G, Monforte Ad, HepaICoNA Study Group, ICoNA Study Group.
    Antivir Ther; 2005; 10(1):109-17. PubMed ID: 15751768
    [Abstract] [Full Text] [Related]

  • 2. Role of hepatitis C virus (HCV) viremia and HCV genotype in the immune recovery from highly active antiretroviral therapy in a cohort of antiretroviral-naive HIV-infected individuals.
    Antonucci G, Girardi E, Cozzi-Lepri A, Capobianchi MR, De Luca A, Puoti M, Petrelli E, Carnevale G, Rizzardini G, Grossi PA, Viganò P, Moioli MC, Carletti F, Solmone M, Ippolito G, Monforte AD, HepaI.Co.N.A. Study Group, Italian Cohort Naive for Antiretrovirals Study Group.
    Clin Infect Dis; 2005 Jun 15; 40(12):e101-9. PubMed ID: 15909251
    [Abstract] [Full Text] [Related]

  • 3. Characterization of GBV-C infection in HIV-1 infected patients.
    Canducci F, Uberti Foppa C, Boeri E, Racca S, Gallotta G, Grasso MA, Calori G, Lazzarin A, Clementi M.
    J Biol Regul Homeost Agents; 2003 Jun 15; 17(2):191-4. PubMed ID: 14518722
    [Abstract] [Full Text] [Related]

  • 4. Effect of GB virus C on response to antiretroviral therapy in HIV-infected Brazilians.
    Souza IE, Zhang W, Diaz RS, Chaloner K, Klinzman D, Stapleton JT.
    HIV Med; 2006 Jan 15; 7(1):25-31. PubMed ID: 16313289
    [Abstract] [Full Text] [Related]

  • 5. Clinical impact of GB virus C viremia on patients with HIV type 1 infection in the era of highly active antiretroviral therapy.
    Sheng WH, Hung CC, Wu RJ, Wang JT, Chen PJ, Chang SC, Kao JH.
    Clin Infect Dis; 2007 Feb 15; 44(4):584-90. PubMed ID: 17243064
    [Abstract] [Full Text] [Related]

  • 6. Effect of GB virus C coinfection on response to antiretroviral treatment in human immunodeficiency virus-infected patients.
    Rodriguez B, Woolley I, Lederman MM, Zdunek D, Hess G, Valdez H.
    J Infect Dis; 2003 Feb 01; 187(3):504-7. PubMed ID: 12552436
    [Abstract] [Full Text] [Related]

  • 7. GB virus C coinfection and HIV-1 disease progression: The Amsterdam Cohort Study.
    Van der Bij AK, Kloosterboer N, Prins M, Boeser-Nunnink B, Geskus RB, Lange JM, Coutinho RA, Schuitemaker H.
    J Infect Dis; 2005 Mar 01; 191(5):678-85. PubMed ID: 15688280
    [Abstract] [Full Text] [Related]

  • 8. Enhanced and resumed GB virus C replication in HIV-1-infected individuals receiving HAART.
    Björkman P, Flamholc L, Molnegren V, Marshall A, Güner N, Widell A.
    AIDS; 2007 Jul 31; 21(12):1641-3. PubMed ID: 17630561
    [Abstract] [Full Text] [Related]

  • 9. Immunological and virological responses to highly active antiretroviral therapy in a non-clinical trial setting in a developing Caribbean country.
    Kilaru KR, Kumar A, Sippy N, Carter AO, Roach TC.
    HIV Med; 2006 Mar 31; 7(2):99-104. PubMed ID: 16420254
    [Abstract] [Full Text] [Related]

  • 10. Evaluation of circulating natural type 1 interferon-producing cells in HIV/GBV-C and HIV/HCV coinfected patients: a preliminary study.
    Haji Molla Hoseini M, Pourfathollah AA, Mohraz M, Soheili Z, Amini S, Aghaiepour M, Samiee S, Nikoogoftar M, Meshkani R.
    Arch Med Res; 2007 Nov 31; 38(8):868-75. PubMed ID: 17923269
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Impact of GB virus type C infection on mother-to-child HIV transmission in the Women and Infants Transmission Study Cohort.
    Handelsman E, Cheng I, Thompson B, Hershow R, Mofenson LM, Hollinger FB, Chen KT, Burchett SK, Klinzman D, Stapleton JT, Women and Infants Transmission Study Group (WITS).
    HIV Med; 2007 Nov 31; 8(8):561-7. PubMed ID: 17944690
    [Abstract] [Full Text] [Related]

  • 13. Influence of hepatitis C virus infection on HIV-1 disease progression and response to highly active antiretroviral therapy.
    Rockstroh JK, Mocroft A, Soriano V, Tural C, Losso MH, Horban A, Kirk O, Phillips A, Ledergerber B, Lundgren J, EuroSIDA Study Group.
    J Infect Dis; 2005 Sep 15; 192(6):992-1002. PubMed ID: 16107951
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. No association between GB virus-C viremia and virological or immunological failure after starting initial antiretroviral therapy.
    Brumme ZL, Chan KJ, Dong WW, Mo T, Wynhoven B, Hogg RS, Montaner JS, O'Shaughnessy MV, Harrigan PR.
    AIDS; 2002 Sep 27; 16(14):1929-33. PubMed ID: 12351953
    [Abstract] [Full Text] [Related]

  • 17. Infection with GB virus C and reduced mortality among HIV-infected patients.
    Tillmann HL, Heiken H, Knapik-Botor A, Heringlake S, Ockenga J, Wilber JC, Goergen B, Detmer J, McMorrow M, Stoll M, Schmidt RE, Manns MP.
    N Engl J Med; 2001 Sep 06; 345(10):715-24. PubMed ID: 11547740
    [Abstract] [Full Text] [Related]

  • 18. Effect of GB virus C co-infection on response to generic HAART in African patients with HIV-1 clade C infection.
    Mosam A, Sathar MA, Dawood H, Cassol E, Esterhuizen TM, Coovadia HM.
    AIDS; 2007 Jun 19; 21(10):1377-9. PubMed ID: 17545721
    [Abstract] [Full Text] [Related]

  • 19. Frequency and genotype of GB virus C among Iranian patients infected with HIV.
    Hekmat S, Mohraz M, Vahabpour R, Jam S, Bahramali G, Banifazl M, Aghakhani A, Eslamifar A, Mahboudi F, Edalat R, Ramezani A.
    J Med Virol; 2008 Nov 19; 80(11):1941-6. PubMed ID: 18814233
    [Abstract] [Full Text] [Related]

  • 20. Influence of hepatitis G virus (GB virus C) on the prognosis of HIV-infected women.
    Campos AF, Tengan FM, Silva SA, Levi JE.
    Int J STD AIDS; 2011 Apr 19; 22(4):209-13. PubMed ID: 21515753
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.